vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
0.00
-0.5520 (-1.73%)
Apr 29, 2026, 9:39 AM EDT - Market open
vTv Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
26
Market Cap
396.73M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Puma Biotechnology | 228.37M |
| Vanda Pharmaceuticals | 216.11M |
| Niagen Bioscience | 129.42M |
| Century Therapeutics | 109.16M |
| Autolus Therapeutics | 75.39M |
| Enanta Pharmaceuticals | 66.98M |
| Invivyd | 53.43M |
| X4 Pharmaceuticals | 35.11M |
VTVT News
- 21 days ago - vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - vTv Therapeutics to Participate in the 38th Annual ROTH Conference - GlobeNewsWire
- 7 weeks ago - vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - vTv Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737 - GlobeNewsWire
- 4 months ago - vTv Therapeutics and M42's IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health - GlobeNewsWire
- 6 months ago - vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - vTv Therapeutics Announces New Appointments to its Scientific Advisory Board - GlobeNewsWire